OptiNose, Inc. (OPTN)
NASDAQ: OPTN · Real-Time Price · USD
0.420
-0.002 (-0.45%)
Dec 20, 2024, 4:00 PM EST - Market closed
OptiNose Employees
OptiNose had 132 employees as of December 31, 2023. The number of employees decreased by 9 or -6.38% compared to the previous year.
Employees
132
Change (1Y)
-9
Growth (1Y)
-6.38%
Revenue / Employee
$573,273
Profits / Employee
-$235,970
Market Cap
63.36M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
111, Inc. | 1,520 |
Burning Rock Biotech | 786 |
Agenus | 389 |
InterCure | 270 |
IceCure Medical | 77 |
Cue Biopharma | 53 |
Forian | 37 |
SELLAS Life Sciences Group | 16 |
OPTN News
- 19 days ago - Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - OptiNose, Inc. (OPTN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights - GlobeNewsWire
- 6 weeks ago - Optinose Announces Reporting Date for Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Optinose Appoints Terry Kohler as Chief Financial Officer - GlobeNewsWire
- 3 months ago - New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery - GlobeNewsWire
- 4 months ago - Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire